Medication info
Zartan Tablet 100 mg (Losartan Potassium)

Zartan Tablet 100 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
Shinil Pharm Co., Ltd.
Appearance
White, capsule-shaped film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200502156 · Notified 2005.08.30 · Insurance code 653802270

Summary

Main use
Treatment of nephropathy in patients with hypertension and type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients aged 75 or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretic treatment), an initial dose of 25 mg of this medicine once daily is recommended (see the Precautions for Use section). A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg once daily, and the dose may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg once daily, and the dose may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Shinil Pharm Co., Ltd.

Efficacy & effects

Treatment of nephropathy in patients with hypertension and type 2 diabetes mellitus

  • Hypertension
  • kidney disease
View approved original text

This medication is used for the treatment of hypertension and helps slow the progression of kidney disease, particularly in patients with type 2 diabetes who have hypertension. It is used to manage health by controlling blood pressure and protecting kidney function.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients aged 75 or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretic treatment), an initial dose of 25 mg of this medicine once daily is recommended (see the Precautions for Use section). A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg once daily, and the dose may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg once daily, and the dose may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters; therefore, women who are pregnant or may become pregnant should not take it. Patients with allergic reactions to this medication, severe liver disease, or certain hereditary lactose intolerance should not use it. Elderly patients, those with impaired kidney function, and patients with hyperkalemia should use this medication with caution and should regularly monitor blood pressure and kidney function. This medication is generally safe but may cause side effects such as dizziness, muscle cramps, back pain, cough, and dyspepsia; rare occurrences of angioedema or liver function abnormalities may also occur. Particular attention should be given due to the possibility of significant drops in blood pressure leading to faintness or shock symptoms; if these symptoms occur, medical attention should be sought immediately. If taken with other antihypertensive medications or potassium supplements, the serum potassium level may rise to dangerous levels; therefore, it is critical to consult a physician before use. Women who are pregnant or breastfeeding should consult a doctor before taking this medication, as it may harm the fetus or newborn, and it is advisable to avoid this medication while breastfeeding. This medication is metabolized by specific enzymes, thus grapefruit juice should be avoided, and possible interactions with other drugs should be discussed with healthcare providers. While taking this medication, regular blood tests and blood pressure measurements are necessary to reduce the risk of hyperkalemia, kidney function abnormalities, and hypotension. In cases of overdose, hypotension and heart arrhythmias may occur, and immediate medical attention is needed for appropriate treatment. This medication is not to be given to children, especially those under 6 years of age or those with severe kidney impairment. Dizziness or drowsiness may occur; therefore, caution is advised when driving or operating machinery.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
  • upper respiratory infection
Show 141 more
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • neuroirritability
  • dysesthesia
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • thoracic discomfort
  • alopecia
  • dermatitis
  • skin dryness
  • petechiae
  • erythema
  • flushing
  • photosensitivity
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • ocular burning
  • pain in the eye
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision impairment
  • erectile dysfunction
  • nocturia
  • frequency of urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased BUN
  • increased serum creatinine
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • elevated serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • atrial fibrillation
  • hypoglycemia
  • weight loss
  • delayed physical development
  • delayed behavioral development
  • increased mortality
  • nephrotoxicity
  • immature
  • intrauterine growth retardation
  • patent ductus arteriosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is also best stored in a cool and dry place, at a temperature between 15 degrees and 30 degrees Celsius. Proper storage can help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

White, capsule-shaped film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.